Drugs being pulled off of shelves because of bad odors generally have no health risks associated with them, but they cost drugmakers money and consumers inconvenience. Pfizer ($PFE) subsidiary King Pharmaceuticals is recalling 52,000 bottles of its thyroid pill Levoxyl because of a bad odor. The problem was tracked to the oxygen-absorbing canisters in 100-count and 1,000-count bottles but the company decided to pull all of its supplies as a precaution, which landed it on the FDA shortage list. The company said it does not expect to have supplies until 2014. Story | More (PDF)